期刊文献+

局部进展期乳腺癌新辅助化疗及保乳手术后放疗24例报告

原文传递
导出
摘要 乳腺癌的新辅助化疗是指对乳腺癌患者在局部治疗之前所给予的全身化疗,亦称术前化疗或诱导化疗。有研究表明,新辅助化疗可以显著地抑制乳腺癌细胞的增殖,减少新生血管的生成,降低组织学的分级。部分局部进展期乳腺癌患者经新辅助化疗后具备了保乳条件。对这部分患者进行保乳手术,局部复发风险高,术后预防照射目前还没有统一的标准。
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2008年第5期527-528,共2页 Chinese Journal of Radiological Medicine and Protection
  • 相关文献

参考文献7

  • 1王深明,张国淳,吴惠茜,黄雪玲,朱彩霞.新辅助化疗对局部进展期乳腺癌的临床疗效以及细胞和血管组织学的影响[J].岭南现代临床外科,2003,3(4):284-287. 被引量:3
  • 2Harris JR, Levene MB, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy for stages Ⅰ and Ⅱ carcinoma of the breast, Int J Radiat Oncol Biol Phys, 1979,5 (2) : 257-261.
  • 3Bonadonna G, Veronesi U, Brambilli C, et al. Primary chemotherapy to avoidmasteetomy in tumors with diameters or three centimeters of more. J Natl Cancer Inst, 1990,82(19) : 1539-1545.
  • 4Parmar V, Krishnamurthy A, Hawaldar R, et al. Breast conservation treatment in women with locally advanced breast cancer-Experlence from a single centre. Int J Surg, 2006,4(2):106-114.
  • 5单文彬,高俊.乳癌根治术与改良根治术163例临床分析[J].中国交通医学杂志,2004,18(4):379-380. 被引量:1
  • 6Heng SH, Cheng FH, Clarke JL, et al. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys,2006,64(5) : 1401-1409.
  • 7程琳,乔新民,杨德启,佟富中,周波,曹迎明,刘鹏,刘宏军,王殊,刘淼,张嘉庆.乳腺癌保乳手术治疗148例分析[J].中国微创外科杂志,2004,4(4):276-278. 被引量:43

二级参考文献15

  • 1黄志清,阚秀,虞有智,董建强,麻为民.乳腺癌中PCNA表达及其与组织学分级的关系[J].临床与实验病理学杂志,1996,12(4):295-297. 被引量:25
  • 2李兰芝.乳腺癌标准根治术与仿根治术对预后的影响[J].实用外科杂志,1986,6(11):577-577.
  • 3[2]Fisher B,Anderson S.Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials.World J Surgy,1994,18(1):63-69.
  • 4[3]Veronesi U,Banfi A,Salvadori B,et al.Breast conservation is the treatment of choice in small breast cancer :long-term results of a randomized trial.Eur J Cancer,1990,26:668-670.
  • 5[4]Early Breast Cancer Trailists Collaboration Group.Effects of radiotherapy and surgery in early breast cancer.An overview of the randomized trials.N Engl J Med,1995,333:1444-1455.
  • 6[5]Winchester DJ,Menck HR,Winchester DP.The National Cancer Data Base report on the results of a large non-randomized comparison of breast preservation and modified radical mastectomy.Cancer,1997,80:162-167.
  • 7[6]Rouzier R,Extra JM,Carton M,et al.Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.J Clin Oncol,2001,19: 3828-3825.
  • 8[7]Fredriksson I,Liljegren G,Arnesson LG,et al.Consequences of axillary recurrence after conservative breast surgery.Br J Surg,2002,89:902-908.
  • 9[8]Fisher B,Dignam J ,Wolmark N,et al.Tamoxifen and chemotherapy for lymph node-negative,estrogen receptor -positive breast cancer.J Natl Cancer Inst,1997,89:1673-1682.
  • 10[9]Julien JP,Bijker N,Fentiman LS,et al.Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase Ⅲ trial 10853.Lancet,2000,355:528-533.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部